Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Renal urate transporters are a group of membrane proteins in the kidney that regulate the reabsorption and secretion of uric acid. These transporters are primarily located in the proximal tubules of the nephron and play a critical role in maintaining uric acid homeostasis. Dysfunction or genetic variation in these proteins can lead to hyperuricemia or hypouricemia, contributing to gout or increased risk for kidney stones/crystal formation. Major renal urate transporters include URAT1, GLUT9, OAT1, OAT3, OAT4, OAT10, NPT4, and MRP4. URAT1 is a major drug target, with inhibitors like lesinurad developed for treatment-resistant gout.
Inhibition of renal urate reabsorption
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Renal Urate Transporter.